Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Examining Anti-VEGF Biosimilars in the Management of Retinal Diseases
Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
4
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
5